A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model

European Journal of Surgical Oncology

Volumn 33, Issue 10, 2007, Pages 1191-1198

  Yoneyama, S ^a   Okaji, Y ^a   Tsuno, N H ^a   Kawai, K ^a   Yamashita, H ^a   Tsuchiya, T ^a   Yamada, J ^a   Sunami, E ^a   Osada, T ^a   Kitayama, J ^a   Takahashi, K ^a   Nagawa, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; Dendritic cells; Endothelium; Metastasis; Vaccine

Indexed keywords

DENDRITIC CELL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIBODY DETECTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER INHIBITION; CELL INTERACTION; CELL LYSATE; COLON CANCER; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST CULTURE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOPHARMACOLOGY; IN VITRO STUDY; LUNG METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUBCUTANEOUS TISSUE TUMOR; T LYMPHOCYTE ACTIVATION; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CELL COMMUNICATION; CELL LINE, TUMOR; CELLS, CULTURED; COLONIC NEOPLASMS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; IMMUNE TOLERANCE; IMMUNOTHERAPY; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 34848889733     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.01.013     Document Type: Article

References (29)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Wang R.F., and Rosenberg S.A. Human tumor antigens for cancer vaccine development. Immunol Rev 170 (1999) 85-100
3. Thurner B., Haendle I., Roder C., et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 190 (1999) 1669-1678
4. Marincola F.M., Jaffee E.M., Hicklin D.J., and Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74 (2000) 181-273
5. Kim R., Emi M., Tanabe K., and Arihiro K. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res 66 (2006) 5527-5536
6. Okaji Y., Tsuno N.H., Saito S., et al. Vaccines targeting tumour angiogenesis-a novel strategy for cancer immunotherapy. Eur J Surg Oncol 32 (2006) 363-370
7. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82 (1990) 4-6
8. Fidler I.J., and Ellis L.M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79 (1994) 185-188
9. Modzelewski R.A., Davies P., Watkins S.C., Auerbach R., Chang M.J., and Johnson C.S. Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma. Cancer Res 54 (1994) 336-339
10. Naumov G.N., Akslen L.A., and Folkman J. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5 (2006) 1779-1787
11. Folkman J., and Kalluri R. Cancer without disease. Nature 427 (2004) 787
12. Okaji Y., Tsuno N.H., Kitayama J., et al. Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity. Cancer Sci 95 (2004) 85-90
13. Lu L., Hsieh M., Oriss T.B., et al. Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses. Immunology 84 (1995) 127-134
14. Li Y., Newby S.A., Johnston J.V., Hellstrom K.E., and Chen L. Protective immunity induced by B7/CD28-costimulated gamma delta T cells to the EL-4 lymphoma in allogenic athymic mice. J Immunol 155 (1995) 5705-5710
15. Li Y., Wang M.N., Li H., et al. Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis. J Exp Med 195 (2002) 1575-1584
16. Wada S., Tsunoda T., Baba T., et al. Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2. Cancer Res 65 (2005) 4939-4946
17. Hu B., Wei Y., Tian L., et al. Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor. J Immunother 28 (2005) 236-244
18. Itoh K., and Yamada A. Personalized peptide vaccines: a new therapeutic modality for cancer. Cancer Sci 97 (2006) 970-976
19. Brossart P., and Bevan M.J. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90 (1997) 1594-1599
20. Shen Z., Reznikoff G., Dranoff G., and Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158 (1997) 2723-2730
21. Gervaz P., Scholl B., Mainguene C., Poitry S., Gillet M., and Wexner S. Angiogenesis of liver metastases: role of sinusoidal endothelial cells. Dis Colon Rectum 43 (2000) 980-986
22. Lou Y.Y., Wei Y.Q., Yang L., et al. Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3. Immunol Invest 31 (2002) 51-69
23. Wei Y.Q., Wang Q.R., Zhao X., et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 6 (2000) 1160-1166
24. Hlatky L., Hahnfeldt P., and Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 94 (2002) 883-893
25. Carson-Walter E.B., Watkins D.N., Nanda A., Vogelstein B., Kinzler K.W., and St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 61 (2001) 6649-6655
26. St Croix B., Rago C., Velculescu V., et al. Genes expressed in human tumor endothelium. Science 289 (2000) 1197-1202
27. Kim A., Noh Y.W., Kim K.D., Jang Y.S., Choe Y.K., and Lim J.S. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination. Exp Mol Med 36 (2004) 428-443
28. Kim K.D., Kim J.K., Kim S.J., et al. Protective antitumor activity through dendritic cell immunization is mediated by NK cell as well as CTL activation. Arch Pharm Res 22 (1999) 340-347
29. Nakamura M., Kikuchi T., Kufe D.W., and Ohno T. Antitumor effects of fusions composed of dendritic cells and fibroblasts transfected with genomic DNA from tumor cells. Cancer Immunol Immunother 53 (2004) 690-696